Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Amicus receives notification of PDUFA date extensions for AT-GAA » 16:05
05/10/22
05/10
16:05
05/10/22
16:05
FOLD

Amicus

$6.76 /

+0.52 (+8.34%)

Amicus Therapeutics…

Amicus Therapeutics announced that the U.S. Food and Drug Administration, FDA, has extended the review period by 90 days for the Biologics License Application, BLA, for cipaglucosidase alfa and the New Drug Application, NDA, for miglustat, the two components of AT-GAA. The revised PDUFA action dates for miglustat and cipaglucosidase alfa are August 29, 2022 and October 29, 2022, respectively. The Company continues to expect the FDA to approve the applications together. "We continue to work collaboratively with the FDA as it completes its review of the AT-GAA applications," said John Crowley, Chairman and Chief Executive Officer at Amicus Therapeutics. "We want to thank the FDA for its continued diligence during the review process. We remain deeply committed to bringing AT-GAA to as many people living with Pompe disease as quickly as possible and delivering on our promise to become the potential new standard of care."

ShowHide Related Items >><<
FOLD Amicus
$6.76 /

+0.52 (+8.34%)

FOLD Amicus
$6.76 /

+0.52 (+8.34%)

04/13/22 Goldman Sachs
Amicus reinstated with a Neutral at Goldman Sachs
01/13/22 SVB Securities
Amicus upgraded to Outperform at SVB Leerink after physician survey
01/13/22 SVB Securities
Amicus upgraded to Outperform from Market Perform at SVB Leerink
01/10/22 Stifel
Amicus weakness likely on preliminary Galafold sales, says Stifel
FOLD Amicus
$6.76 /

+0.52 (+8.34%)

FOLD Amicus
$6.76 /

+0.52 (+8.34%)

On The Fly
What You Missed On Wall Street On Monday » 17:07
05/09/22
05/09
17:07
05/09/22
17:07
PCOM

Points International

$24.49 /

+7.32 (+42.63%)

, DIS

Disney

$107.00 /

-3.28 (-2.97%)

, DISH

Dish

$21.31 /

-0.92 (-4.14%)

, SPCE

Virgin Galactic

$6.07 /

-0.735 (-10.81%)

, TSN

Tyson Foods

$92.77 /

+1.925 (+2.12%)

, PLTR

Palantir

$7.45 /

-2.02 (-21.33%)

, IMAX

Imax

$15.26 /

-0.62 (-3.91%)

, PM

Philip Morris

$99.87 /

+0.93 (+0.94%)

, SWMAY

Swedish Match

$9.40 /

+1.78 (+23.36%)

, MTCH

Match Group

$70.73 /

-3.32 (-4.48%)

, IHRT

iHeartMedia

$12.27 /

-1.74 (-12.42%)

, APLD

Applied Blockchain

$2.83 /

-0.665 (-19.03%)

, F

Ford

$13.37 /

-0.84 (-5.91%)

, UBER

Uber

$23.04 /

-3.045 (-11.67%)

, TWTR

Twitter

$47.99 /

-1.81 (-3.63%)

, LMT

Lockheed Martin

$439.00 /

-9.68 (-2.16%)

, GS

Goldman Sachs

$308.93 /

-3.86 (-1.23%)

, VTRS

Viatris

$10.50 /

+0.565 (+5.69%)

, FOLD

Amicus

$6.24 /

-0.02 (-0.32%)

, BEKE

KE Holdings

$11.36 /

-0.92 (-7.49%)

, PAGS

PagSeguro Digital

$10.76 /

-1.57 (-12.74%)

, RIDE

Lordstown Motors

$1.78 /

-0.135 (-7.05%)

, APRN

Blue Apron

$3.37 /

+0.12 (+3.69%)

, PRTY

Party City

$1.18 /

-1.885 (-61.60%)

, TGNA

Tegna

$21.18 /

-0.63 (-2.89%)

, EXC

Exelon

$46.74 /

-0.29 (-0.62%)

, HSKA

Heska

$89.95 /

-11.32 (-11.18%)

Get caught up quickly on…

ShowHide Related Items >><<
VTRS Viatris
$10.50 /

+0.565 (+5.69%)

UBER Uber
$23.04 /

-3.045 (-11.67%)

TWTR Twitter
$47.99 /

-1.81 (-3.63%)

TSN Tyson Foods
$92.77 /

+1.925 (+2.12%)

TGNA Tegna
$21.18 /

-0.63 (-2.89%)

SPCE Virgin Galactic
$6.07 /

-0.735 (-10.81%)

RIDE Lordstown Motors
$1.78 /

-0.135 (-7.05%)

PRTY Party City
$1.18 /

-1.885 (-61.60%)

PM Philip Morris
$99.87 /

+0.93 (+0.94%)

PLTR Palantir
$7.45 /

-2.02 (-21.33%)

PCOM Points International
$24.49 /

+7.32 (+42.63%)

PAGS PagSeguro Digital
$10.76 /

-1.57 (-12.74%)

MTCH Match Group
$70.73 /

-3.32 (-4.48%)

LMT Lockheed Martin
$439.00 /

-9.68 (-2.16%)

IMAX Imax
$15.26 /

-0.62 (-3.91%)

IHRT iHeartMedia
$12.27 /

-1.74 (-12.42%)

GS Goldman Sachs
$308.93 /

-3.86 (-1.23%)

FOLD Amicus
$6.24 /

-0.02 (-0.32%)

F Ford
$13.37 /

-0.84 (-5.91%)

EXC Exelon
$46.74 /

-0.29 (-0.62%)

DISH Dish
$21.31 /

-0.92 (-4.14%)

DIS Disney
$107.00 /

-3.28 (-2.97%)

BEKE KE Holdings
$11.36 /

-0.92 (-7.49%)

APRN Blue Apron
$3.37 /

+0.12 (+3.69%)

APLD Applied Blockchain
$2.83 /

-0.665 (-19.03%)

PCOM Points International
$24.49 /

+7.32 (+42.63%)

05/09/22 Barrington
Points International downgraded to Underperform from Outperform at Barrington
08/12/21 Northland
Points International upgraded to Outperform from Market Perform at Northland
08/12/21 Northland
Points International upgraded to Outperform from Market Perform at Northland
05/18/21 Barrington
Points International price target raised to $22 from $18 at Barrington
DIS Disney
$107.00 /

-3.28 (-2.97%)

05/09/22 BofA
Coca-Cola, Kraft Heinz added to 'US 1' list at BofA
04/26/22 Deutsche Bank
Deutsche Bank sees Disney being unharmed from Florida vote
04/19/22 JPMorgan
Disney price target lowered to $175 from $200 at JPMorgan
04/19/22 Rosenblatt
Disney initiated with a Buy at Rosenblatt
DISH Dish
$21.31 /

-0.92 (-4.14%)

05/09/22 Raymond James
Dish price target lowered to $42 from $49 at Raymond James
05/09/22 Benchmark
Dish price target lowered to $37 from $50 at Benchmark
05/09/22 Deutsche Bank
Dish price target lowered to $61 from $67 at Deutsche Bank
05/09/22 JPMorgan
JPMorgan downgrades Dish with 'little path for investor excitement'
SPCE Virgin Galactic
$6.07 /

-0.735 (-10.81%)

05/09/22 Truist
Virgin Galactic downgraded to Hold from Buy at Truist
05/09/22 Truist
Virgin Galactic downgraded to Hold from Buy at Truist
05/06/22 Canaccord
Virgin Galactic downgraded to Hold at Canaccord after commercial launch delay
05/06/22 Canaccord
Virgin Galactic downgraded to Hold from Buy at Canaccord
TSN Tyson Foods
$92.77 /

+1.925 (+2.12%)

05/03/22 Piper Sandler
Tyson Foods downgraded to Underweight from Neutral at Piper Sandler
03/14/22 BMO Capital
Tyson Foods downgraded to Market Perform from Outperform at BMO Capital
02/14/22 Barclays
Tyson Foods downgraded on limited potential upside at Barclays
02/14/22 Barclays
Tyson Foods downgraded to Equal Weight from Overweight at Barclays
PLTR Palantir
$7.45 /

-2.02 (-21.33%)

05/10/22 Deutsche Bank
Palantir price target lowered to $11 from $15 at Deutsche Bank
05/10/22 Citi
Palantir price target lowered to $7 from $10 at Citi
05/09/22 RBC Capital
RBC downgrades Palantir to sell, halves target after 'disappointing' Q1
05/09/22 RBC Capital
Palantir downgraded to Underperform from Sector Perform at RBC Capital
IMAX Imax
$15.26 /

-0.62 (-3.91%)

05/02/22 Barrington
Imax price target lowered to $20 from $25 at Barrington
03/01/22 Benchmark
Benchmark sees limited financial impact to Imax from Russia
02/24/22 Benchmark
Benchmark keeps a Buy rating on Imax, raises price target to $28
02/23/22 Benchmark
Imax's Q4 saw cinema recovery business accelerate, says Benchmark
PM Philip Morris
$99.87 /

+0.93 (+0.94%)

05/10/22 Bernstein
Altria Group downgraded to Market Perform from Outperform at Bernstein
05/10/22 JPMorgan
Swedish Match upgraded to Neutral from Underweight at JPMorgan
05/09/22 Jefferies
PM buying Swedish Match would have negative read for Altria, says Jefferies
04/24/22 BofA
Philip Morris price target raised to $117 from $107 at BofA
SWMAY Swedish Match
$9.40 /

+1.78 (+23.36%)

04/12/22 Credit Suisse
Swedish Match price target raised to SEK 88 from SEK 78 at Credit Suisse
03/31/22 JPMorgan
Swedish Match price target raised to SEK 66 from SEK 64 at JPMorgan
MTCH Match Group
$70.73 /

-3.32 (-4.48%)

05/10/22 Piper Sandler
Match Group suit against Google not surprising, says Piper Sandler
05/09/22 Wells Fargo
Wells Fargo upgrades Match Group to Overweight, lowers price target to $115
05/09/22 Wells Fargo
Match Group upgraded to Overweight from Equal Weight at Wells Fargo
05/05/22 RBC Capital
Match Group price target lowered to $115 from $150 at RBC Capital
IHRT iHeartMedia
$12.27 /

-1.74 (-12.42%)

05/09/22 JPMorgan
iHeartMedia downgraded to Neutral from Overweight at JPMorgan
05/06/22 B. Riley
iHeartMedia price target lowered to $36 from $40 at B. Riley
10/20/21 B. Riley
iHeartMedia price target lowered to $39 from $42 at B. Riley
09/08/21 B. Riley
iHeartMedia price target raised to $42 from $36 at B. Riley
APLD Applied Blockchain
$2.83 /

-0.665 (-19.03%)

05/09/22 Lake Street
Applied Blockchain initiated with a Buy at Lake Street
05/09/22 Northland
Applied Blockchain initiated with an Outperform at Northland
05/09/22 B. Riley
Applied Blockchain initiated with a Buy at B. Riley
05/09/22 Needham
Applied Blockchain initiated with a Buy at Needham
F Ford
$13.37 /

-0.84 (-5.91%)

05/10/22 Berenberg
Ford initiated with a Hold at Berenberg
05/02/22 Benchmark
Ford price target lowered to $25 from $29 at Benchmark
04/28/22 Barclays
Ford Q1 may bring 'relief rally' in shares, says Barclays
04/25/22 JPMorgan
Ford price target lowered to $21 from $22 at JPMorgan
UBER Uber
$23.04 /

-3.045 (-11.67%)

05/05/22 Oppenheimer
Uber price target lowered to $40 from $45 at Oppenheimer
05/05/22 MKM Partners
Uber price target lowered to $41 from $65 at MKM Partners
05/05/22 Needham
Uber price target lowered to $50 from $68 at Needham
05/05/22 Wedbush
Uber price target lowered to $38 from $48 at Wedbush
TWTR Twitter
$47.99 /

-1.81 (-3.63%)

05/05/22 Argus
Twitter downgraded to Hold at Argus after board approves Musk buyout
05/05/22 Argus
Twitter downgraded to Hold from Buy at Argus
04/29/22 Evercore ISI
Evercore 'impressed' by Snap's product innovation after partner summit
04/28/22 Piper Sandler
Twitter price target raised to $51.50 from $46 at Piper Sandler
LMT Lockheed Martin
$439.00 /

-9.68 (-2.16%)

04/20/22 Argus
Lockheed Martin price target raised to $500 from $415 at Argus
04/20/22 Wells Fargo
Lockheed Martin price target raised to $496 from $486 at Wells Fargo
04/20/22 Susquehanna
Lockheed Martin price target raised to $539 from $515 at Susquehanna
04/08/22 Canaccord
Canaccord starts 'premier' small satellite maker Terran Orbital at Buy
GS Goldman Sachs
$308.93 /

-3.86 (-1.23%)

05/03/22 Oppenheimer
Goldman Sachs price target lowered to $519 from $546 at Oppenheimer
04/18/22 Gordon Haskett
Block director exit notable due to 'overlap' language, says Gordon Haskett
04/18/22 BMO Capital
Goldman Sachs price target lowered to $486 from $488 at BMO Capital
04/05/22 Piper Sandler
Goldman Sachs price target lowered to $430 from $465 at Piper Sandler
VTRS Viatris
$10.50 /

+0.565 (+5.69%)

05/10/22 Piper Sandler
Viatris downgraded to Underweight from Neutral at Piper Sandler
03/16/22 Piper Sandler
Viatris price target lowered to $10 from $17 at Piper Sandler
03/10/22 Citi
Viatris price target lowered to $11 from $16 at Citi
03/01/22 BMO Capital
Viatris price target lowered to $19 from $23 at BMO Capital
FOLD Amicus
$6.24 /

-0.02 (-0.32%)

04/13/22 Goldman Sachs
Amicus reinstated with a Neutral at Goldman Sachs
01/13/22 SVB Securities
Amicus upgraded to Outperform at SVB Leerink after physician survey
01/13/22 SVB Securities
Amicus upgraded to Outperform from Market Perform at SVB Leerink
01/10/22 Stifel
Amicus weakness likely on preliminary Galafold sales, says Stifel
BEKE KE Holdings
$11.36 /

-0.92 (-7.49%)

04/18/22 UBS
KE Holdings upgraded to Buy from Neutral at UBS
04/10/22 Goldman Sachs
KE Holdings assumed with a Buy at Goldman Sachs
03/16/22 Morgan Stanley
KE Holdings upgraded to Overweight at Morgan Stanley with turnaround seen coming
03/16/22 Morgan Stanley
KE Holdings upgraded to Overweight from Equal Weight at Morgan Stanley
PAGS PagSeguro Digital
$10.76 /

-1.57 (-12.74%)

05/09/22 New Street
PagSeguro Digital downgraded to Neutral from Buy at New Street
05/02/22 Susquehanna
PagSeguro Digital price target lowered to $26 from $38 at Susquehanna
04/14/22 Piper Sandler
PagSeguro initiated with Overweight, $22 target at Piper Sandler
04/13/22 Piper Sandler
PagSeguro Digital initiated with an Overweight at Piper Sandler
RIDE Lordstown Motors
$1.78 /

-0.135 (-7.05%)

05/10/22 R.F. Lafferty
Lordstown Motors downgraded to Sell from Hold at R.F. Lafferty
05/10/22 Deutsche Bank
Lordstown Motors price target lowered to $2 from $3 at Deutsche Bank
03/01/22 R.F. Lafferty
Lordstown Motors price target lowered to $4 from $7 at R.F. Lafferty
03/01/22 Deutsche Bank
Lordstown Motors price target lowered to $3 from $7 at Deutsche Bank
APRN Blue Apron
$3.37 /

+0.12 (+3.69%)

05/10/22 Canaccord
Blue Apron price target lowered to $10 from $12 at Canaccord
02/10/22 Canaccord
Blue Apron price target lowered to $12 from $15 at Canaccord
PRTY Party City
$1.18 /

-1.885 (-61.60%)

TGNA Tegna
$21.18 /

-0.63 (-2.89%)

05/05/22 Wells Fargo
Wells Fargo downgrades Tegna to Equal Weight, ups price target to $24
05/04/22 Wells Fargo
Tegna downgraded to Equal Weight from Overweight at Wells Fargo
04/13/22 Argus
Tegna downgraded to Hold from Buy at Argus
09/22/21 Barrington
Tegna downgraded to Market Perform from Outperform at Barrington
EXC Exelon
$46.74 /

-0.29 (-0.62%)

04/20/22 JPMorgan
Exelon upgraded to Overweight on pure-play transition at JPMorgan
04/20/22 JPMorgan
Exelon upgraded to Overweight from Neutral at JPMorgan
03/11/22 Mizuho
Exelon upgraded to Buy from Neutral at Mizuho
02/17/22 BMO Capital
Exelon price target lowered to $47 from $63 at BMO Capital
HSKA Heska
$89.95 /

-11.32 (-11.18%)

05/10/22 Alliance Global Partners
Heska price target lowered to $150 from $240 at Alliance Global Partners
05/09/22 Piper Sandler
Heska should be bought ahead of next week's analyst day, says Piper Sandler
05/04/22 Piper Sandler
Piper Sandler says buy Heska, report will differ from Idexx
03/17/22 Piper Sandler
Heska price target lowered to $190 from $210 at Piper Sandler
VTRS Viatris
$10.50 /

+0.565 (+5.69%)

UBER Uber
$23.04 /

-3.045 (-11.67%)

TWTR Twitter
$47.99 /

-1.81 (-3.63%)

TSN Tyson Foods
$92.77 /

+1.925 (+2.12%)

TGNA Tegna
$21.18 /

-0.63 (-2.89%)

SPCE Virgin Galactic
$6.07 /

-0.735 (-10.81%)

RIDE Lordstown Motors
$1.78 /

-0.135 (-7.05%)

PRTY Party City
$1.18 /

-1.885 (-61.60%)

PM Philip Morris
$99.87 /

+0.93 (+0.94%)

PLTR Palantir
$7.45 /

-2.02 (-21.33%)

PCOM Points International
$24.49 /

+7.32 (+42.63%)

PAGS PagSeguro Digital
$10.76 /

-1.57 (-12.74%)

MTCH Match Group
$70.73 /

-3.32 (-4.48%)

LMT Lockheed Martin
$439.00 /

-9.68 (-2.16%)

IMAX Imax
$15.26 /

-0.62 (-3.91%)

IHRT iHeartMedia
$12.27 /

-1.74 (-12.42%)

HSKA Heska
$89.95 /

-11.32 (-11.18%)

GS Goldman Sachs
$308.93 /

-3.86 (-1.23%)

FOLD Amicus
$6.24 /

-0.02 (-0.32%)

F Ford
$13.37 /

-0.84 (-5.91%)

EXC Exelon
$46.74 /

-0.29 (-0.62%)

DISH Dish
$21.31 /

-0.92 (-4.14%)

DIS Disney
$107.00 /

-3.28 (-2.97%)

BEKE KE Holdings
$11.36 /

-0.92 (-7.49%)

APRN Blue Apron
$3.37 /

+0.12 (+3.69%)

  • 13
    Apr
  • 29
    Jul
  • 16
    Jun
VTRS Viatris
$10.50 /

+0.565 (+5.69%)

UBER Uber
$23.04 /

-3.045 (-11.67%)

TWTR Twitter
$47.99 /

-1.81 (-3.63%)

TSN Tyson Foods
$92.77 /

+1.925 (+2.12%)

TGNA Tegna
$21.18 /

-0.63 (-2.89%)

RIDE Lordstown Motors
$1.78 /

-0.135 (-7.05%)

PM Philip Morris
$99.87 /

+0.93 (+0.94%)

PLTR Palantir
$7.45 /

-2.02 (-21.33%)

LMT Lockheed Martin
$439.00 /

-9.68 (-2.16%)

IHRT iHeartMedia
$12.27 /

-1.74 (-12.42%)

GS Goldman Sachs
$308.93 /

-3.86 (-1.23%)

F Ford
$13.37 /

-0.84 (-5.91%)

DISH Dish
$21.31 /

-0.92 (-4.14%)

DIS Disney
$107.00 /

-3.28 (-2.97%)

BEKE KE Holdings
$11.36 /

-0.92 (-7.49%)

APRN Blue Apron
$3.37 /

+0.12 (+3.69%)

VTRS Viatris
$10.50 /

+0.565 (+5.69%)

UBER Uber
$23.04 /

-3.045 (-11.67%)

TWTR Twitter
$47.99 /

-1.81 (-3.63%)

TSN Tyson Foods
$92.77 /

+1.925 (+2.12%)

TGNA Tegna
$21.18 /

-0.63 (-2.89%)

SPCE Virgin Galactic
$6.07 /

-0.735 (-10.81%)

RIDE Lordstown Motors
$1.78 /

-0.135 (-7.05%)

PRTY Party City
$1.18 /

-1.885 (-61.60%)

PM Philip Morris
$99.87 /

+0.93 (+0.94%)

PLTR Palantir
$7.45 /

-2.02 (-21.33%)

PCOM Points International
$24.49 /

+7.32 (+42.63%)

PAGS PagSeguro Digital
$10.76 /

-1.57 (-12.74%)

MTCH Match Group
$70.73 /

-3.32 (-4.48%)

LMT Lockheed Martin
$439.00 /

-9.68 (-2.16%)

IMAX Imax
$15.26 /

-0.62 (-3.91%)

IHRT iHeartMedia
$12.27 /

-1.74 (-12.42%)

GS Goldman Sachs
$308.93 /

-3.86 (-1.23%)

FOLD Amicus
$6.24 /

-0.02 (-0.32%)

F Ford
$13.37 /

-0.84 (-5.91%)

EXC Exelon
$46.74 /

-0.29 (-0.62%)

DISH Dish
$21.31 /

-0.92 (-4.14%)

DIS Disney
$107.00 /

-3.28 (-2.97%)

BEKE KE Holdings
$11.36 /

-0.92 (-7.49%)

APRN Blue Apron
$3.37 /

+0.12 (+3.69%)

APLD Applied Blockchain
$2.83 /

-0.665 (-19.03%)

VTRS Viatris
$10.50 /

+0.565 (+5.69%)

UBER Uber
$23.04 /

-3.045 (-11.67%)

TWTR Twitter
$47.99 /

-1.81 (-3.63%)

TSN Tyson Foods
$92.77 /

+1.925 (+2.12%)

SPCE Virgin Galactic
$6.07 /

-0.735 (-10.81%)

RIDE Lordstown Motors
$1.78 /

-0.135 (-7.05%)

PM Philip Morris
$99.87 /

+0.93 (+0.94%)

PLTR Palantir
$7.45 /

-2.02 (-21.33%)

PAGS PagSeguro Digital
$10.76 /

-1.57 (-12.74%)

MTCH Match Group
$70.73 /

-3.32 (-4.48%)

LMT Lockheed Martin
$439.00 /

-9.68 (-2.16%)

GS Goldman Sachs
$308.93 /

-3.86 (-1.23%)

F Ford
$13.37 /

-0.84 (-5.91%)

EXC Exelon
$46.74 /

-0.29 (-0.62%)

DISH Dish
$21.31 /

-0.92 (-4.14%)

DIS Disney
$107.00 /

-3.28 (-2.97%)

BEKE KE Holdings
$11.36 /

-0.92 (-7.49%)

APRN Blue Apron
$3.37 /

+0.12 (+3.69%)

On The Fly
What You Missed On Wall Street This Morning » 12:00
05/09/22
05/09
12:00
05/09/22
12:00
HSKA

Heska

$90.57 /

-10.7 (-10.57%)

, CBIO

Catalyst Biosciences

/

+

, EXC

Exelon

$46.71 /

-0.32 (-0.68%)

, TGNA

Tegna

$21.40 /

-0.41 (-1.88%)

, APRN

Blue Apron

$3.28 /

+0.03 (+0.92%)

, RIDE

Lordstown Motors

$1.75 /

-0.17 (-8.88%)

, PAGS

PagSeguro Digital

$10.85 /

-1.48 (-12.01%)

, BEKE

KE Holdings

$10.87 /

-1.41 (-11.48%)

, FOLD

Amicus

$6.25 /

-0.005 (-0.08%)

, VTRS

Viatris

$10.50 /

+0.565 (+5.69%)

, LMT

Lockheed Martin

$442.92 /

-5.76 (-1.28%)

, AAPL

Apple

$153.07 /

-4.28 (-2.72%)

, TSLA

Tesla

$811.85 /

-55.25 (-6.37%)

, TWTR

Twitter

$48.49 /

-1.31 (-2.63%)

, UBER

Uber

$24.18 /

-1.905 (-7.30%)

, RIVN

Rivian Automotive

$24.66 /

-4.125 (-14.33%)

, APLD

Applied Blockchain

$3.18 /

-0.315 (-9.01%)

, IHRT

iHeartMedia

$12.50 /

-1.505 (-10.75%)

, MTCH

Match Group

$72.06 /

-1.99 (-2.69%)

, SPCE

Virgin Galactic

$6.26 /

-0.54 (-7.94%)

, DISH

Dish

$21.77 /

-0.455 (-2.05%)

, DIS

Disney

$107.93 /

-2.35 (-2.13%)

, IMAX

Imax

$15.20 /

-0.675 (-4.25%)

, PRTY

Party City

$1.44 /

-1.625 (-53.10%)

, PCOM

Points International

$24.48 /

+7.31 (+42.57%)

, PLTR

Palantir

$7.52 /

-1.95 (-20.59%)

, TSN

Tyson Foods

$91.28 /

+0.435 (+0.48%)

Get caught up quickly on…

ShowHide Related Items >><<
VTRS Viatris
$10.50 /

+0.565 (+5.69%)

UBER Uber
$24.18 /

-1.905 (-7.30%)

TWTR Twitter
$48.49 /

-1.31 (-2.63%)

TSN Tyson Foods
$91.28 /

+0.435 (+0.48%)

TSLA Tesla
$811.85 /

-55.25 (-6.37%)

TGNA Tegna
$21.40 /

-0.41 (-1.88%)

SPCE Virgin Galactic
$6.26 /

-0.54 (-7.94%)

RIVN Rivian Automotive
$24.66 /

-4.125 (-14.33%)

RIDE Lordstown Motors
$1.75 /

-0.17 (-8.88%)

PRTY Party City
$1.44 /

-1.625 (-53.10%)

PLTR Palantir
$7.52 /

-1.95 (-20.59%)

PCOM Points International
$24.48 /

+7.31 (+42.57%)

PAGS PagSeguro Digital
$10.85 /

-1.48 (-12.01%)

MTCH Match Group
$72.06 /

-1.99 (-2.69%)

LMT Lockheed Martin
$442.92 /

-5.76 (-1.28%)

IMAX Imax
$15.20 /

-0.675 (-4.25%)

IHRT iHeartMedia
$12.50 /

-1.505 (-10.75%)

FOLD Amicus
$6.25 /

-0.005 (-0.08%)

EXC Exelon
$46.71 /

-0.32 (-0.68%)

DISH Dish
$21.77 /

-0.455 (-2.05%)

DIS Disney
$107.93 /

-2.35 (-2.13%)

CBIO Catalyst Biosciences
/

+

BEKE KE Holdings
$10.87 /

-1.41 (-11.48%)

APRN Blue Apron
$3.28 /

+0.03 (+0.92%)

APLD Applied Blockchain
$3.18 /

-0.315 (-9.01%)

AAPL Apple
$153.07 /

-4.28 (-2.72%)

HSKA Heska
$90.57 /

-10.7 (-10.57%)

05/09/22 Piper Sandler
Heska should be bought ahead of next week's analyst day, says Piper Sandler
05/04/22 Piper Sandler
Piper Sandler says buy Heska, report will differ from Idexx
03/17/22 Piper Sandler
Heska price target lowered to $190 from $210 at Piper Sandler
03/02/22 Alliance Global Partners
Heska price target lowered to $240 from $310 at Alliance Global Partners
CBIO Catalyst Biosciences
/

+

03/31/22 Piper Sandler
Piper says 'stick it out' with Catalyst Biosciences exploring options
11/12/21 JonesTrading
Catalyst Biosciences downgraded to Hold from Buy at JonesTrading
11/12/21 Piper Sandler
Catalyst Biosciences price target lowered to $4 from $16 at Piper Sandler
11/12/21 Raymond James
Catalyst Biosciences downgraded to Market Perform from Outperform at Raymond James
EXC Exelon
$46.71 /

-0.32 (-0.68%)

04/20/22 JPMorgan
Exelon upgraded to Overweight on pure-play transition at JPMorgan
04/20/22 JPMorgan
Exelon upgraded to Overweight from Neutral at JPMorgan
03/11/22 Mizuho
Exelon upgraded to Buy from Neutral at Mizuho
02/17/22 BMO Capital
Exelon price target lowered to $47 from $63 at BMO Capital
TGNA Tegna
$21.40 /

-0.41 (-1.88%)

05/05/22 Wells Fargo
Wells Fargo downgrades Tegna to Equal Weight, ups price target to $24
05/04/22 Wells Fargo
Tegna downgraded to Equal Weight from Overweight at Wells Fargo
04/13/22 Argus
Tegna downgraded to Hold from Buy at Argus
09/22/21 Barrington
Tegna downgraded to Market Perform from Outperform at Barrington
APRN Blue Apron
$3.28 /

+0.03 (+0.92%)

02/10/22 Canaccord
Blue Apron price target lowered to $12 from $15 at Canaccord
RIDE Lordstown Motors
$1.75 /

-0.17 (-8.88%)

03/01/22 R.F. Lafferty
Lordstown Motors price target lowered to $4 from $7 at R.F. Lafferty
03/01/22 Deutsche Bank
Lordstown Motors price target lowered to $3 from $7 at Deutsche Bank
01/04/22 Morgan Stanley
Ferrari replacing GM as Morgan Stanley's new 'Top Pick' in U.S. autos
11/12/21 R.F. Lafferty
R.F. Lafferty upgrades Lordstown to Hold on better odds for Endurance production
PAGS PagSeguro Digital
$10.85 /

-1.48 (-12.01%)

05/09/22 New Street
PagSeguro Digital downgraded to Neutral from Buy at New Street
05/02/22 Susquehanna
PagSeguro Digital price target lowered to $26 from $38 at Susquehanna
04/14/22 Piper Sandler
PagSeguro initiated with Overweight, $22 target at Piper Sandler
04/13/22 Piper Sandler
PagSeguro Digital initiated with an Overweight at Piper Sandler
BEKE KE Holdings
$10.87 /

-1.41 (-11.48%)

04/18/22 UBS
KE Holdings upgraded to Buy from Neutral at UBS
04/10/22 Goldman Sachs
KE Holdings assumed with a Buy at Goldman Sachs
03/16/22 Morgan Stanley
KE Holdings upgraded to Overweight at Morgan Stanley with turnaround seen coming
03/16/22 Morgan Stanley
KE Holdings upgraded to Overweight from Equal Weight at Morgan Stanley
FOLD Amicus
$6.25 /

-0.005 (-0.08%)

04/13/22 Goldman Sachs
Amicus reinstated with a Neutral at Goldman Sachs
01/13/22 SVB Securities
Amicus upgraded to Outperform at SVB Leerink after physician survey
01/13/22 SVB Securities
Amicus upgraded to Outperform from Market Perform at SVB Leerink
01/10/22 Stifel
Amicus weakness likely on preliminary Galafold sales, says Stifel
VTRS Viatris
$10.50 /

+0.565 (+5.69%)

03/16/22 Piper Sandler
Viatris price target lowered to $10 from $17 at Piper Sandler
03/10/22 Citi
Viatris price target lowered to $11 from $16 at Citi
03/01/22 BMO Capital
Viatris price target lowered to $19 from $23 at BMO Capital
03/01/22 Raymond James
Viatris downgraded to Market Perform from Outperform at Raymond James
LMT Lockheed Martin
$442.92 /

-5.76 (-1.28%)

04/20/22 Argus
Lockheed Martin price target raised to $500 from $415 at Argus
04/20/22 Wells Fargo
Lockheed Martin price target raised to $496 from $486 at Wells Fargo
04/20/22 Susquehanna
Lockheed Martin price target raised to $539 from $515 at Susquehanna
04/08/22 Canaccord
Canaccord starts 'premier' small satellite maker Terran Orbital at Buy
AAPL Apple
$153.07 /

-4.28 (-2.72%)

05/04/22 Benchmark
Cirrus Logic price target lowered to $95 from $100 at Benchmark
05/04/22 Benchmark
Skyworks price target lowered to $155 from $190 at Benchmark
05/04/22 KeyBanc
Cirrus Logic price target lowered to $105 from $120 at KeyBanc
05/03/22 Cowen
Enovix order 'perhaps' from Apple or Google, says Cowen
TSLA Tesla
$811.85 /

-55.25 (-6.37%)

04/27/22 Wedbush
Twitter transaction 'was never ideal' for Tesla investors, says Wedbush
04/26/22 Wedbush
'Soap opera' now ends with Musk owning Twitter, says Wedbush
04/25/22 Gordon Haskett
Twitter bid more attractive after market selloff, says Gordon Haskett
04/25/22 Wedbush
Twitter bid unlikely to result in major sale of Musk's Tesla stock, says Wedbush
TWTR Twitter
$48.49 /

-1.31 (-2.63%)

05/05/22 Argus
Twitter downgraded to Hold at Argus after board approves Musk buyout
05/05/22 Argus
Twitter downgraded to Hold from Buy at Argus
04/29/22 Evercore ISI
Evercore 'impressed' by Snap's product innovation after partner summit
04/28/22 Piper Sandler
Twitter price target raised to $51.50 from $46 at Piper Sandler
UBER Uber
$24.18 /

-1.905 (-7.30%)

05/05/22 Oppenheimer
Uber price target lowered to $40 from $45 at Oppenheimer
05/05/22 MKM Partners
Uber price target lowered to $41 from $65 at MKM Partners
05/05/22 Needham
Uber price target lowered to $50 from $68 at Needham
05/05/22 Wedbush
Uber price target lowered to $38 from $48 at Wedbush
RIVN Rivian Automotive
$24.66 /

-4.125 (-14.33%)

05/02/22 Piper Sandler
Piper Sandler favors Rivian for exposure to commercial vans
05/02/22 Benchmark
Ford price target lowered to $25 from $29 at Benchmark
04/26/22 Barclays
Rivian Automotive price target lowered to $38 from $42 at Barclays
04/25/22 JPMorgan
Ford price target lowered to $21 from $22 at JPMorgan
APLD Applied Blockchain
$3.18 /

-0.315 (-9.01%)

05/09/22 Lake Street
Applied Blockchain initiated with a Buy at Lake Street
05/09/22 Northland
Applied Blockchain initiated with an Outperform at Northland
05/09/22 B. Riley
Applied Blockchain initiated with a Buy at B. Riley
05/09/22 Needham
Applied Blockchain initiated with a Buy at Needham
IHRT iHeartMedia
$12.50 /

-1.505 (-10.75%)

05/09/22 JPMorgan
iHeartMedia downgraded to Neutral from Overweight at JPMorgan
05/06/22 B. Riley
iHeartMedia price target lowered to $36 from $40 at B. Riley
10/20/21 B. Riley
iHeartMedia price target lowered to $39 from $42 at B. Riley
09/08/21 B. Riley
iHeartMedia price target raised to $42 from $36 at B. Riley
MTCH Match Group
$72.06 /

-1.99 (-2.69%)

05/09/22 Wells Fargo
Wells Fargo upgrades Match Group to Overweight, lowers price target to $115
05/09/22 Wells Fargo
Match Group upgraded to Overweight from Equal Weight at Wells Fargo
05/05/22 RBC Capital
Match Group price target lowered to $115 from $150 at RBC Capital
05/05/22 Wedbush
Match Group price target lowered to $98 from $130 at Wedbush
SPCE Virgin Galactic
$6.26 /

-0.54 (-7.94%)

05/09/22 Truist
Virgin Galactic downgraded to Hold from Buy at Truist
05/09/22 Truist
Virgin Galactic downgraded to Hold from Buy at Truist
05/06/22 Canaccord
Virgin Galactic downgraded to Hold at Canaccord after commercial launch delay
05/06/22 Canaccord
Virgin Galactic downgraded to Hold from Buy at Canaccord
DISH Dish
$21.77 /

-0.455 (-2.05%)

05/09/22 Raymond James
Dish price target lowered to $42 from $49 at Raymond James
05/09/22 Benchmark
Dish price target lowered to $37 from $50 at Benchmark
05/09/22 Deutsche Bank
Dish price target lowered to $61 from $67 at Deutsche Bank
05/09/22 JPMorgan
JPMorgan downgrades Dish with 'little path for investor excitement'
DIS Disney
$107.93 /

-2.35 (-2.13%)

05/09/22 BofA
Coca-Cola, Kraft Heinz added to 'US 1' list at BofA
04/26/22 Deutsche Bank
Deutsche Bank sees Disney being unharmed from Florida vote
04/19/22 JPMorgan
Disney price target lowered to $175 from $200 at JPMorgan
04/19/22 Rosenblatt
Disney initiated with a Buy at Rosenblatt
IMAX Imax
$15.20 /

-0.675 (-4.25%)

05/02/22 Barrington
Imax price target lowered to $20 from $25 at Barrington
03/01/22 Benchmark
Benchmark sees limited financial impact to Imax from Russia
02/24/22 Benchmark
Benchmark keeps a Buy rating on Imax, raises price target to $28
02/23/22 Benchmark
Imax's Q4 saw cinema recovery business accelerate, says Benchmark
PRTY Party City
$1.44 /

-1.625 (-53.10%)

PCOM Points International
$24.48 /

+7.31 (+42.57%)

05/09/22 Barrington
Points International downgraded to Underperform from Outperform at Barrington
08/12/21 Northland
Points International upgraded to Outperform from Market Perform at Northland
08/12/21 Northland
Points International upgraded to Outperform from Market Perform at Northland
05/18/21 Barrington
Points International price target raised to $22 from $18 at Barrington
PLTR Palantir
$7.52 /

-1.95 (-20.59%)

04/22/22 Piper Sandler
Palantir price target raised to $16 from $15 at Piper Sandler
04/19/22 RBC Capital
Palantir upgraded to Sector Perform from Underperform at RBC Capital
04/11/22 Monness Crespi
Palantir initiated with a Buy at Monness Crespi
03/09/22 Piper Sandler
Palantir initiated with an Overweight at Piper Sandler
TSN Tyson Foods
$91.28 /

+0.435 (+0.48%)

05/03/22 Piper Sandler
Tyson Foods downgraded to Underweight from Neutral at Piper Sandler
03/14/22 BMO Capital
Tyson Foods downgraded to Market Perform from Outperform at BMO Capital
02/14/22 Barclays
Tyson Foods downgraded on limited potential upside at Barclays
02/14/22 Barclays
Tyson Foods downgraded to Equal Weight from Overweight at Barclays
VTRS Viatris
$10.50 /

+0.565 (+5.69%)

UBER Uber
$24.18 /

-1.905 (-7.30%)

TWTR Twitter
$48.49 /

-1.31 (-2.63%)

TSN Tyson Foods
$91.28 /

+0.435 (+0.48%)

TSLA Tesla
$811.85 /

-55.25 (-6.37%)

TGNA Tegna
$21.40 /

-0.41 (-1.88%)

SPCE Virgin Galactic
$6.26 /

-0.54 (-7.94%)

RIVN Rivian Automotive
$24.66 /

-4.125 (-14.33%)

RIDE Lordstown Motors
$1.75 /

-0.17 (-8.88%)

PRTY Party City
$1.44 /

-1.625 (-53.10%)

PLTR Palantir
$7.52 /

-1.95 (-20.59%)

PCOM Points International
$24.48 /

+7.31 (+42.57%)

PAGS PagSeguro Digital
$10.85 /

-1.48 (-12.01%)

MTCH Match Group
$72.06 /

-1.99 (-2.69%)

LMT Lockheed Martin
$442.92 /

-5.76 (-1.28%)

IMAX Imax
$15.20 /

-0.675 (-4.25%)

IHRT iHeartMedia
$12.50 /

-1.505 (-10.75%)

HSKA Heska
$90.57 /

-10.7 (-10.57%)

FOLD Amicus
$6.25 /

-0.005 (-0.08%)

EXC Exelon
$46.71 /

-0.32 (-0.68%)

DISH Dish
$21.77 /

-0.455 (-2.05%)

DIS Disney
$107.93 /

-2.35 (-2.13%)

CBIO Catalyst Biosciences
/

+

BEKE KE Holdings
$10.87 /

-1.41 (-11.48%)

APRN Blue Apron
$3.28 /

+0.03 (+0.92%)

AAPL Apple
$153.07 /

-4.28 (-2.72%)

  • 13
    Apr
  • 10
    Nov
  • 29
    Jul
  • 16
    Jun
VTRS Viatris
$10.50 /

+0.565 (+5.69%)

UBER Uber
$24.18 /

-1.905 (-7.30%)

TWTR Twitter
$48.49 /

-1.31 (-2.63%)

TSN Tyson Foods
$91.28 /

+0.435 (+0.48%)

TSLA Tesla
$811.85 /

-55.25 (-6.37%)

TGNA Tegna
$21.40 /

-0.41 (-1.88%)

RIVN Rivian Automotive
$24.66 /

-4.125 (-14.33%)

RIDE Lordstown Motors
$1.75 /

-0.17 (-8.88%)

PLTR Palantir
$7.52 /

-1.95 (-20.59%)

LMT Lockheed Martin
$442.92 /

-5.76 (-1.28%)

IHRT iHeartMedia
$12.50 /

-1.505 (-10.75%)

DISH Dish
$21.77 /

-0.455 (-2.05%)

DIS Disney
$107.93 /

-2.35 (-2.13%)

BEKE KE Holdings
$10.87 /

-1.41 (-11.48%)

APRN Blue Apron
$3.28 /

+0.03 (+0.92%)

AAPL Apple
$153.07 /

-4.28 (-2.72%)

VTRS Viatris
$10.50 /

+0.565 (+5.69%)

UBER Uber
$24.18 /

-1.905 (-7.30%)

TWTR Twitter
$48.49 /

-1.31 (-2.63%)

TSN Tyson Foods
$91.28 /

+0.435 (+0.48%)

TSLA Tesla
$811.85 /

-55.25 (-6.37%)

TGNA Tegna
$21.40 /

-0.41 (-1.88%)

RIDE Lordstown Motors
$1.75 /

-0.17 (-8.88%)

PRTY Party City
$1.44 /

-1.625 (-53.10%)

PLTR Palantir
$7.52 /

-1.95 (-20.59%)

PAGS PagSeguro Digital
$10.85 /

-1.48 (-12.01%)

MTCH Match Group
$72.06 /

-1.99 (-2.69%)

LMT Lockheed Martin
$442.92 /

-5.76 (-1.28%)

IMAX Imax
$15.20 /

-0.675 (-4.25%)

IHRT iHeartMedia
$12.50 /

-1.505 (-10.75%)

HSKA Heska
$90.57 /

-10.7 (-10.57%)

FOLD Amicus
$6.25 /

-0.005 (-0.08%)

EXC Exelon
$46.71 /

-0.32 (-0.68%)

DIS Disney
$107.93 /

-2.35 (-2.13%)

BEKE KE Holdings
$10.87 /

-1.41 (-11.48%)

APRN Blue Apron
$3.28 /

+0.03 (+0.92%)

APLD Applied Blockchain
$3.18 /

-0.315 (-9.01%)

AAPL Apple
$153.07 /

-4.28 (-2.72%)

VTRS Viatris
$10.50 /

+0.565 (+5.69%)

UBER Uber
$24.18 /

-1.905 (-7.30%)

TWTR Twitter
$48.49 /

-1.31 (-2.63%)

TSN Tyson Foods
$91.28 /

+0.435 (+0.48%)

TSLA Tesla
$811.85 /

-55.25 (-6.37%)

SPCE Virgin Galactic
$6.26 /

-0.54 (-7.94%)

RIVN Rivian Automotive
$24.66 /

-4.125 (-14.33%)

RIDE Lordstown Motors
$1.75 /

-0.17 (-8.88%)

PLTR Palantir
$7.52 /

-1.95 (-20.59%)

PAGS PagSeguro Digital
$10.85 /

-1.48 (-12.01%)

MTCH Match Group
$72.06 /

-1.99 (-2.69%)

LMT Lockheed Martin
$442.92 /

-5.76 (-1.28%)

EXC Exelon
$46.71 /

-0.32 (-0.68%)

DISH Dish
$21.77 /

-0.455 (-2.05%)

DIS Disney
$107.93 /

-2.35 (-2.13%)

BEKE KE Holdings
$10.87 /

-1.41 (-11.48%)

APRN Blue Apron
$3.28 /

+0.03 (+0.92%)

AAPL Apple
$153.07 /

-4.28 (-2.72%)

Earnings
Amicus sees FY22 Galafold revenue $350M-$365M » 07:53
05/09/22
05/09
07:53
05/09/22
07:53
FOLD

Amicus

$6.26 /

-0.345 (-5.23%)

Double-digit revenue…

Double-digit revenue growth between 15 and 20% at CER1 in 2022 is expected to be driven by continued underlying demand from both switch and naive patients, geographic expansion, the continued diagnosis of new Fabry patients and commercial execution across all major markets, including the U.S., EU, U.K., and Japan. Applying average April 2022 exchange rates, the negative currency impact on full-year 2022 Galafold reported sales would be approximately 6%. Non-GAAP operating expense guidance for the full-year 2022 is $470 million to $485 million. Cash, cash equivalents, and marketable securities totaled $411.2 million at March 31, 2022. Based on current operating models, the Company believes that the current and projected cash flows are sufficient to achieve self-sustainability.

ShowHide Related Items >><<
FOLD Amicus
$6.26 /

-0.345 (-5.23%)

FOLD Amicus
$6.26 /

-0.345 (-5.23%)

04/13/22 Goldman Sachs
Amicus reinstated with a Neutral at Goldman Sachs
01/13/22 SVB Securities
Amicus upgraded to Outperform at SVB Leerink after physician survey
01/13/22 SVB Securities
Amicus upgraded to Outperform from Market Perform at SVB Leerink
01/10/22 Stifel
Amicus weakness likely on preliminary Galafold sales, says Stifel
FOLD Amicus
$6.26 /

-0.345 (-5.23%)

FOLD Amicus
$6.26 /

-0.345 (-5.23%)

Hot Stocks
Amicus announces anticipated 2022 milestones » 07:52
05/09/22
05/09
07:52
05/09/22
07:52
FOLD

Amicus

$6.26 /

-0.345 (-5.23%)

Galafold Oral Precision…

Galafold Oral Precision Medicine for Fabry Disease: Sustain double-digit revenue growth in 2022 of $350 million to $365 million at CER; Continue geographic expansion; and Registry and other Phase 4 studies ongoing. AT-GAA for Pompe Disease: U.S. Prescription Drug User Fee Act action date of May 29, 2022 for the NDA and July 29, 2022 for the BLA; EU Committee for Medicinal Products for Human Use opinion expected in late 2022; Continue to broaden early access plans in the U.K., Germany, France, Japan, and other countries; Ongoing supportive studies, including pediatric and extension studies

ShowHide Related Items >><<
FOLD Amicus
$6.26 /

-0.345 (-5.23%)

FOLD Amicus
$6.26 /

-0.345 (-5.23%)

04/13/22 Goldman Sachs
Amicus reinstated with a Neutral at Goldman Sachs
01/13/22 SVB Securities
Amicus upgraded to Outperform at SVB Leerink after physician survey
01/13/22 SVB Securities
Amicus upgraded to Outperform from Market Perform at SVB Leerink
01/10/22 Stifel
Amicus weakness likely on preliminary Galafold sales, says Stifel
FOLD Amicus
$6.26 /

-0.345 (-5.23%)

FOLD Amicus
$6.26 /

-0.345 (-5.23%)

Earnings
Amicus reports Q1 EPS (30c), consensus (25c) » 07:31
05/09/22
05/09
07:31
05/09/22
07:31
FOLD

Amicus

$6.26 /

-0.345 (-5.23%)

Reports Q1 revenue…

Reports Q1 revenue $78.715M, consensus $77.13M. John Crowley, Chairman and Chief Executive Officer of Amicus Therapeutics, Inc., stated, "Against a tumultuous market, we at Amicus have a deeply sharpened focus. We continue to ensure that Galafold gets to as many amenable people living with Fabry disease around the world, as seen by the significant first quarter performance of this precision medicine. We are committed to the regulatory approvals of AT-GAA for people living with Pompe disease, first in the United States and then in Europe and beyond. We are well on track with these anticipated approvals and the associated launch preparations, furthering our belief in the potential for this treatment regimen to become the new global standard of care in Pompe disease. And finally, we are laser focused on the financial strength of the business. This is anchored by the continued growth of Galafold and the anticipated approval of AT-GAA, each with strong exclusivity well into the late 2030s. Together this uniquely positions Amicus to deliver substantial value for shareholders and patients ahead."

ShowHide Related Items >><<
FOLD Amicus
$6.26 /

-0.345 (-5.23%)

FOLD Amicus
$6.26 /

-0.345 (-5.23%)

04/13/22 Goldman Sachs
Amicus reinstated with a Neutral at Goldman Sachs
01/13/22 SVB Securities
Amicus upgraded to Outperform at SVB Leerink after physician survey
01/13/22 SVB Securities
Amicus upgraded to Outperform from Market Perform at SVB Leerink
01/10/22 Stifel
Amicus weakness likely on preliminary Galafold sales, says Stifel
FOLD Amicus
$6.26 /

-0.345 (-5.23%)

FOLD Amicus
$6.26 /

-0.345 (-5.23%)

Hot Stocks
Amicus announces issuance of US patent for Galafold » 07:10
04/19/22
04/19
07:10
04/19/22
07:10
FOLD

Amicus

$7.93 /

-0.265 (-3.23%)

Amicus Therapeutics…

Amicus Therapeutics announced that the United States Patent and Trademark Office, USPTO, has issued U.S. Patent No. 11,304,940, which is directed to a composition of matter covering migalastat, or Galafold. The new U.S. patent titled "Methods of Treating Fabry Patients Having Renal Impairments" is directed to a molecule comprising migalastat bound to an alpha-galactosidase A protein and expires in 2038. John Crowley, Chairman and Chief Executive Officer of Amicus stated, "We are very pleased that the USPTO has issued this patent around this unique oral pharmacological chaperone, which builds upon our existing intellectual property portfolio and provides patent protection for Galafold to 2038. The issuance of this very important patent embodies the many years of tremendous hard work, perseverance and ingenuity of the Amicus teams as well as the investment of hundreds of millions of dollars to create and deliver this novel precision medicine to people living with Fabry disease with amenable variants. This patent, in concert with our other 34 orange book listed patents and regulatory exclusivities for Galafold, provide Amicus with broad and long-term intellectual property rights well into the late-2030s."

ShowHide Related Items >><<
FOLD Amicus
$7.93 /

-0.265 (-3.23%)

FOLD Amicus
$7.93 /

-0.265 (-3.23%)

04/13/22 Goldman Sachs
Amicus reinstated with a Neutral at Goldman Sachs
01/13/22 SVB Securities
Amicus upgraded to Outperform at SVB Leerink after physician survey
01/13/22 SVB Securities
Amicus upgraded to Outperform from Market Perform at SVB Leerink
01/10/22 Stifel
Amicus weakness likely on preliminary Galafold sales, says Stifel
FOLD Amicus
$7.93 /

-0.265 (-3.23%)

FOLD Amicus
$7.93 /

-0.265 (-3.23%)

Initiation
Amicus reinstated with a Neutral at Goldman Sachs » 06:29
04/13/22
04/13
06:29
04/13/22
06:29
FOLD

Amicus

$8.39 /

+0.06 (+0.72%)

Goldman Sachs analyst…

Goldman Sachs analyst Salveen Richter reinstated coverage of Amicus Therapeutics with a Neutral rating and $11 price target. The analyst is positive on the approval outlook for AT-GAA in Pompe disease but says the company's "quieter R&D effort" via gene therapy programs that are now only entering the clinic in the next several years puts heightened focus on commercial execution.

ShowHide Related Items >><<
FOLD Amicus
$8.39 /

+0.06 (+0.72%)

FOLD Amicus
$8.39 /

+0.06 (+0.72%)

01/13/22 SVB Securities
Amicus upgraded to Outperform at SVB Leerink after physician survey
01/13/22 SVB Securities
Amicus upgraded to Outperform from Market Perform at SVB Leerink
01/10/22 Stifel
Amicus weakness likely on preliminary Galafold sales, says Stifel
11/15/21 Stifel
Amicus upgraded to Buy from Hold at Stifel
FOLD Amicus
$8.39 /

+0.06 (+0.72%)

FOLD Amicus
$8.39 /

+0.06 (+0.72%)

Over a quarter ago
Conference/Events
Amicus participates in a conference call with JPMorgan » 09:52
03/28/22
03/28
09:52
03/28/22
09:52
FOLD

Amicus

$9.40 /

+0.05 (+0.53%)

SMid Cap Biotech Analyst…

SMid Cap Biotech Analyst Rama holds a conference call with CEO Crowley and CFO Campbell on March 28 at 11 am. Webcast Link

ShowHide Related Items >><<
FOLD Amicus
$9.40 /

+0.05 (+0.53%)

FOLD Amicus
$9.40 /

+0.05 (+0.53%)

01/13/22 SVB Securities
Amicus upgraded to Outperform at SVB Leerink after physician survey
01/13/22 SVB Securities
Amicus upgraded to Outperform from Market Perform at SVB Leerink
01/10/22 Stifel
Amicus weakness likely on preliminary Galafold sales, says Stifel
11/15/21 Stifel
Amicus upgraded to Buy from Hold at Stifel
FOLD Amicus
$9.40 /

+0.05 (+0.53%)

FOLD Amicus
$9.40 /

+0.05 (+0.53%)

Hot Stocks
Amicus announces long-term data from Phase 1/2 study of AT-GAA » 07:12
03/16/22
03/16
07:12
03/16/22
07:12
FOLD

Amicus

$8.95 /

+0.345 (+4.01%)

Amicus Therapeutics…

Amicus Therapeutics announced additional positive results from a global Phase 1/2 clinical study, ATB200-02, to investigate AT-GAA in adult patients with Pompe disease, an inherited lysosomal storage disorder caused by an enzyme deficiency that leads to accumulation of glycogen in cells. Study participants treated with AT-GAA for up to 36 months showed persistent and durable effects on six-minute walk test distance and other measures of motor function and muscle strength, stability or increases in forced vital capacity, and reductions in biomarkers of muscle damage and disease substrate. These clinical results are being featured at the 2022 MDA Clinical & Scientific Conference in an oral platform presentation on Wednesday, March 16, 2022. Long-term data from the Phase 3 PROPEL open-label extension study is expected to be presented later this year. ATB200-02 Study Data Highlights in ERT-Experienced and ERT-Naive Patients Out to Month 36, Cohorts 1 - 4: Functional Outcomes: Amongst ERT-naive patients, 6MWT distance increased in 6/6, 5/5, and 4/5 patients at months 12, 24, and 36, respectively. The ERT-naive patients showed mean increases of 57 meters at month 12, 61 meters at month 24, and 44 meters at month 36. 6MWT distance increased in 13/16, 8/10, and 6/8 ERT-experienced patients at months 12, 24, and 36, respectively. The ERT-experienced patients showed mean increases of 34 meters at month 12, 21 meters at month 24, and 48 meters at month 36. Muscle Strength: Ambulatory and non-ambulatory patients, including ERT-experienced and ERT-naive, showed improvements in strength testing as assessed by manual muscle testing (MMT) and improvements were maintained out to 36 months. Pulmonary Function: Pulmonary function improved in ERT-naive patients and was generally stable in ERT-experienced patients. In ERT-naive patients, mean change in percent predicted forced vital capacity, one of the main measures of pulmonary function in Pompe disease, was +4.5% at month 12, +6.8% at month 24, and +6.2% at month 36. In ERT-experienced patients, mean change in % predicted FVC was -1.3% at month 12, -0.9% at month 24, and -0.4% at month 36. Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics in Cohorts 1-4: To date, adverse events have been generally mild and transient; The clinical pharmacokinetic profile has been consistent with previously reported data; Persistent and durable reductions in key biomarkers of muscle damage and disease substrate across all patient cohorts out to month 36 continue to suggest a positive effect on muscle tissue.

ShowHide Related Items >><<
FOLD Amicus
$8.95 /

+0.345 (+4.01%)

FOLD Amicus
$8.95 /

+0.345 (+4.01%)

01/13/22 SVB Securities
Amicus upgraded to Outperform at SVB Leerink after physician survey
01/13/22 SVB Securities
Amicus upgraded to Outperform from Market Perform at SVB Leerink
01/10/22 Stifel
Amicus weakness likely on preliminary Galafold sales, says Stifel
11/15/21 Stifel
Amicus upgraded to Buy from Hold at Stifel
FOLD Amicus
$8.95 /

+0.345 (+4.01%)

FOLD Amicus
$8.95 /

+0.345 (+4.01%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.